Published in Hypertension on May 10, 2010
Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata. Cardiovasc Res (2011) 1.06
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Classical Renin-Angiotensin system in kidney physiology. Compr Physiol (2014) 0.92
Cholinergic neurons in the mouse rostral ventrolateral medulla target sensory afferent areas. Brain Struct Funct (2012) 0.85
Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol (2013) 0.84
In vivo assessment of neurocardiovascular regulation in the mouse: principles, progress, and prospects. Am J Physiol Heart Circ Physiol (2011) 0.84
Afferent and efferent connections of C1 cells with spinal cord or hypothalamic projections in mice. Brain Struct Funct (2015) 0.77
Baroreceptor reflex control of heart rate in angiotensin type 1A receptor knockout mice. Physiol Rep (2013) 0.75
Selective C1 Lesioning Slightly Decreases Angiotensin II Type I Receptor Expression in the Rat Rostral Ventrolateral Medulla (RVLM). Neurochem Res (2015) 0.75
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A (2003) 5.08
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol (2007) 3.82
Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2010) 3.79
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med (2006) 3.11
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes (2006) 2.80
Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg (2008) 2.79
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg (2003) 2.72
Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg (2004) 2.59
Minimally invasive mitral valve surgery after previous sternotomy: experience in 181 patients. Ann Thorac Surg (2009) 2.42
Surgical experience with 77 primary cardiac tumors. Interact Cardiovasc Thorac Surg (2005) 2.23
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg (2008) 2.06
Facilitated minimally invasive left ventricular epicardial lead placement. Ann Thorac Surg (2005) 2.05
AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab (2011) 2.03
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol (2011) 1.98
One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2011) 1.98
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension (2005) 1.89
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol (2002) 1.84
Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension (2006) 1.81
Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy. Hypertension (2009) 1.77
Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg (2011) 1.76
Visceral arterial compromise during intra-aortic balloon counterpulsation therapy. Circulation (2010) 1.68
Transgenic rat model of Huntington's disease. Hum Mol Genet (2003) 1.66
Ablation of atrial fibrillation and esophageal injury: effects of energy source and ablation technique. J Thorac Cardiovasc Surg (2005) 1.65
Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg (2008) 1.65
The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer (2010) 1.62
Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg (2010) 1.62
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res (2008) 1.59
High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med (2002) 1.58
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation (2005) 1.57
Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J Physiol (2008) 1.57
UBF levels determine the number of active ribosomal RNA genes in mammals. J Cell Biol (2008) 1.57
Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis. J Mol Med (Berl) (2002) 1.54
Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg (2004) 1.54
A second prosthesis as a procedural rescue option in trans-apical aortic valve implantation. Eur J Cardiothorac Surg (2011) 1.50
Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta? Ann Thorac Surg (2010) 1.49
Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension. Hypertension (2013) 1.46
Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.45
Effect of preoperative statin therapy on patients undergoing isolated and combined valvular heart surgery. Ann Thorac Surg (2010) 1.44
Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease. Lancet (2003) 1.43
Hypothalamic gene expression in ω-3 PUFA-deficient male rats before, and following, development of hypertension. Hypertens Res (2011) 1.43
Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting. Am Heart J (2011) 1.43
Selective cerebral perfusion using moderate flow in complex cardiac surgery provides sufficient neuroprotection. Are children young adults? Eur J Cardiothorac Surg (2012) 1.43
Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: à ègalité. Ann Thorac Surg (2009) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg (2012) 1.42
Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse. Eur J Cardiothorac Surg (2009) 1.41
Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg (2008) 1.40
Transapical aortic valve implantation off-pump in patients with impaired left ventricular function. Ann Thorac Surg (2011) 1.39
Prognostic significance of circulating levels of hepatocyte growth factor in patients with chagas' disease and idiopathic dilated cardiomyopathy. Cardiology (2012) 1.39
Execution of the meiotic noncoding RNA expression program and the onset of gametogenesis in yeast require the conserved exosome subunit Rrp6. Proc Natl Acad Sci U S A (2010) 1.39
Cardiovascular role of angiotensin type1A receptors in the nucleus of the solitary tract of mice. Cardiovasc Res (2013) 1.39
Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg (2009) 1.32
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) (2011) 1.29
Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation (2011) 1.28
Minimal access aortic valve replacement: effects on morbidity and resource utilization. Ann Thorac Surg (2002) 1.26
Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog. J Pharmacol Exp Ther (2008) 1.26
One-year follow-up of patients undergoing elective cardiac surgery assessed with the Comprehensive Assessment of Frailty test and its simplified form. Interact Cardiovasc Thorac Surg (2011) 1.25
Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth (2009) 1.25
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol (2007) 1.23
Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem (2003) 1.22
Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ Heart Fail (2010) 1.22
G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem (2005) 1.19
Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res (2003) 1.18
Comparison of aortic root measurements in patients undergoing transapical aortic valve implantation (TA-AVI) using three-dimensional rotational angiography (3D-RA) and multislice computed tomography (MSCT): differences and variability. Int J Cardiovasc Imaging (2012) 1.16
Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal (2006) 1.15
Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg (2012) 1.15
Early and mid-term results of mitral valve repair using premeasured Gore-Tex loops ('loop technique'). Eur J Cardiothorac Surg (2008) 1.14
First-in-man evaluation of the transapical APICA ASC™ access and closure device: the initial 10 patients. Eur J Cardiothorac Surg (2013) 1.13
Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol (2011) 1.12
Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension (2004) 1.12
Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One (2009) 1.12
Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J (2005) 1.11
Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides (2005) 1.11
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention (2014) 1.10
On-pump beating heart versus off-pump coronary artery bypass surgery-evidence of pump-induced myocardial injury. Eur J Cardiothorac Surg (2005) 1.10
Secundum ASD closure using a right lateral minithoracotomy: five-year experience in 122 patients. Ann Thorac Surg (2003) 1.09
Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg (2010) 1.09
Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg (2012) 1.09
Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes (2009) 1.09
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J (2004) 1.08
Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med (2003) 1.07
Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J Hypertens (2007) 1.06
Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann Thorac Surg (2007) 1.06
Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata. Cardiovasc Res (2011) 1.06
Primary repair for aortic arch obstruction associated with ventricular septal defect. Ann Thorac Surg (2004) 1.05
Redo aortic valve surgery: early and late outcomes. Ann Thorac Surg (2011) 1.04
Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol (2014) 1.04
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica (2009) 1.03
Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology (2006) 1.03
Automatic aorta segmentation and valve landmark detection in C-arm CT: application to aortic valve implantation. Med Image Comput Comput Assist Interv (2010) 1.02
Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther (2006) 1.02
Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol (2004) 1.02
Awake transapical aortic valve implantation using thoracic epidural anesthesia. Ann Thorac Surg (2009) 1.02